Eliaz Therapeutics
PrivateLast Round
Crowdfunding
Jun 11, 2026
Est. Valuation
$60.08M
Total Funding Raised
$9.61M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Eliaz Therapeutics operates in Healthcare & Life Sciences and is based in Santa Rosa, California. Its latest recorded funding round was a Crowdfunding round in June 2026.
Eliaz Therapeutics is a medical device company developing apheresis technology to selectively remove Galectin-3 from the bloodstream for the treatment of sepsis and other inflammatory conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eliaz Therapeutics Comparables
Compare Eliaz Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Santersus AG | 87% | |
| Alteco Medical AB | 84% | |
| ExThera Medical | 83% |
For institutional investors. Book with your work email.
Eliaz Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Jun 11, 2026 | ||||
| Debt | Dec 31, 2025 | ||||
| Crowdfunding | Nov 1, 2024 | ||||
| Grant | Jun 23, 2022 | ||||
| Series A | Oct 12, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Eliaz Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Institute of General Medical Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 56% MoM, reaching 6K.
- Aug 20, 2026
Monthly visitors grew 54% MoM.
For institutional investors. Book with your work email.
Eliaz Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Eliaz Therapeutics's valuation, stock price, and market status.
Is Eliaz Therapeutics a public or private company?
Eliaz Therapeutics is a private company.
What is the current stock price of Eliaz Therapeutics?
Eliaz Therapeutics is a private company, so its shares have no public market price. Caplight tracks Eliaz Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Eliaz Therapeutics worth (valuation)?
Eliaz Therapeutics's valuation is estimated at $60.1M based on funding round data.
Can I buy Eliaz Therapeutics stock?
Eliaz Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Eliaz Therapeutics's last funding round?
Eliaz Therapeutics's most recent funding round was Crowdfunding on June 11, 2026.
Who are the main investors in Eliaz Therapeutics?
Key investors in Eliaz Therapeutics include NIH RADx, National Institute of General Medical Sciences.
Will Eliaz Therapeutics IPO soon?
No public IPO plans have been announced for Eliaz Therapeutics.
How can I track Eliaz Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Eliaz Therapeutics's shares on secondary markets.